Tag: Schizophrenia

The cumulative evidence challenges the assumption that lifelong antipsychotic treatment is necessary or beneficial for most individuals with schizophrenia.

Psychologist Gail Hornstein discusses her search for the meanings of madness, from asylum artifacts and memoirs to the contemporary peer-support groups reshaping how people understand voices and visions.

In this wide-ranging conversation on public mental health, psychiatrization, and community care, Dinesh Bhugra explains why meaningful lives, not symptom reduction alone, should guide mental healthcare today.

Cultural psychiatrist G. Eric Jarvis discusses religion and mental health, the social determinants of psychosis, and how coercive treatment can deepen mistrust in psychiatric care.

The Accord program in Arlington Massachusetts will provide a test of whether an intensive ketogenic program, when combined with drug-tapering support, can lead to robust recovery over the long term, with diminished use--or no ongoing use--of psychiatric medications.

Justin Garson joins us to talk about the work of Solomon Snyder, whose discoveries ushered in the era of biological psychiatry.

Sol Snyder burned this medical vision so deeply into our collective consciousness that it’s almost impossible to see outside of it.

Kamaldeep Bhui joins us to challenge the myth of clinical neutrality, arguing that culture informs not only patients’ experiences of distress but also clinicians’ judgments about what counts as pathology. From voice-hearing to addiction, meaning depends on context, class, belief systems, and power relations.

September 27, 2025, is the fiftieth anniversary of the ignominious death in prison of my sorely regretted and dearly beloved friend Mark Frechette.

From Med City News. "A Bristol Myers Squibb drug whose landmark FDA approval introduced the first novel mechanism for treating schizophrenia in decades has...

A psychiatrist with lived experience advocates for a more humane, collaborative approach to antipsychotic discontinuation that respects diverse ways of knowing.

A roundup of Mad in America's most read blogs and personal stories of 2024 as chosen by our readers.

The drugs, especially benzos and high doses of antipsychotics, led to an increased risk of death within five years. Antidepressants also did not reduce mortality.

People who are given the diagnosis of “schizophrenia” are the last social group not to be accepted by the public. 

If you are a young schizophrenic, I encourage you to accept the challenge of leading a happy, productive, meaningful life.

A new study shows how different patients respond to tapering antipsychotic medication under expert guidance, highlighting personal empowerment and the complexities of withdrawal.

Author Deborah Kasdan discusses her memoir of her late sister, "Roll Back The World."

Study reveals schizophrenia patients find little support from mental health staff in reducing side effects-heavy drugs.

The “genetics of mental disorders” story told in Kolker's "Hidden Valley Road" involves omission and misrepresentation of genetic research.

From Medium/Rev. Sheri Heller, LCSW: The 'symptom bearer' or 'identified patient' is the scapegoat who carries the evidence of the familial dysfunction.

When people seeking help are relegated to “the Other,” how can they ever form a “therapeutic alliance”? Without collaboration, treatment devolves into coercion and oppression. We must change our language and relationships so new narratives can be born.

Questioning is what I did, but once I started questioning so much of what I had learned and of what my identity had been, it wasn’t obvious to me where I should stop.

New research examines service user attitudes on discontinuing and reducing antipsychotic drugs.

Long-term exposure to prolactin-increasing antipsychotics increases the odds of developing breast cancer.

In JAMA psychiatry, researchers outline new theories connecting antipsychotic use in people with schizophrenia and increased dementia risk.